Comparing the efficacy and safety of Mirikizumab and Etrasimod in treating moderate to severe ulcerative colitis and Crohn’s disease: A systematic review and meta-analysis
Crossref DOI link: https://doi.org/10.30574/wjbphs.2024.20.3.1020
Published Online: 2024-12-30
Update policy: https://doi.org/10.30574/wjbphs.ourcrossmarkpolicy
Sagar Ahammed,
